Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Pharmaceutical Ingredients Mupirocin raw material Powder
Product Overview:
Mupirocin (also known as pseudomonosporic acid A) is an ideal anti-bacterial preparation for the skin surface, which was introduced to the market by GlaxoSmithKline in 1985 under the trade name Bactroban. The United States FDA approved the drug for use in the United States in 1987, and China approved the production and sale of the drug by SmithKline Pharmaceutical in 1993. Mupirocin is mainly used for the prevention and treatment of skin bacterial infections caused by gram-positive bacteria.
Pharmaceutical Ingredients Mupirocin raw material Powder Attributes
CAS:12650-69-0
MF:C26H44O9
MW:500.62
EINECS:603-145-3
Specification: 99% min Mupirocin Powder
Sample:Mupirocin Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Pharmaceutical Ingredients Mupirocin raw material Powder Details
Mupirocin powder Usage and Synthesis.
Mupirocin is mainly used for the prevention and treatment of skin bacterial infections caused by gram-positive coccus, such as impetigo, furuncle, folliculitis and other primary skin infections, and eczema co-infection, ulcer co-infection, trauma co-infection and other secondary skin infections. The main mechanism of mupirocin's antibacterial action is to inhibit protein synthesis in bacteria.
Uses of Mupirocin.
Topical antibiotics. By reversibly binding to isoleucine transfer RNA synthetase, isoleucine is prevented from entering the human body, thus halting the synthesis of all proteins containing isoleucine in the cell. For acute primary bacterial skin infections, such as folliculitis and impetigo. It is generally used for skin disease inflammation, eczema, etc., to make Mupirocin ointment on the market.
Pharmacological action of Mupirocin.
Product Methods of Mupirocin.
A class of substances produced by Pseudomonas fluorescens, including pseudomonas acid A, B, C, D, of which mupirocin is the main metabolite of pseudomonas acid A.
